Targeted screening | Universal | ||||
---|---|---|---|---|---|
≥ age 50† | ≥ age 45 | ≥ age 40 | ≥ age 35 | screening | |
Strategies implemented incrementally* | |||||
Additional % of population screened | - | 24.27 | 20.79 | 20.45 | 18.39 |
Additional coverage of high risk population screened | - | 4.32 | 1.11 | 0.18 | 0.00 |
% of additional high risk individuals detected | - | 4.59 | 1.11 | 0.17 | 0.01 |
Additional NNS to detect 1 high risk individual | - | 9.81 | 41.20 | 309.67 | 7168.90 |
Males | |||||
Additional % of population screened | - | 26.96 | 22.20 | 21.99 | 19.12 |
Additional coverage of high risk population screened | - | 5.62 | 1.53 | 0.25 | 0.00 |
% of additional high risk individuals detected | - | 6.08 | 1.55 | 0.25 | 0.01 |
Additional NNS to detect 1 high risk individual | - | 6.12 | 23.61 | 176.52 | 5179.06 |
Females | |||||
Additional % of population screened | - | 21.88 | 19.49 | 19.00 | 17.67 |
Additional coverage of high risk population screened | - | 1.97 | 0.41 | 0.01 | 0.00 |
% of additional high risk individuals detected | - | 2.04 | 0.36 | 0.05 | 0.01 |
Additional NNS to detect 1 high risk individual | - | 28.53 | 173.39 | 1525.92 | 5876.37 |